First COVID Treatment for Younger Kids is now FDA approved

Mohamad Ali Salloum, PharmD • May 1, 2022

Share

  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button

Remdesivir..


I bet you’ve heard about this molecule during the pandemic.


This molecule was originally approved by FDA in October 2020 for hospitalized patients aged 12 and above. (Their weight should be at least 40 kilograms)


Properties of Remdesivir:


This molecule is an antiviral drug that acts by limiting the SARS-CoV-2 replication. How?


The virus has a machine that can use the human’s cell components to multiply itself. This machine is called the RNA-dependent RNA polymerase.


Remdesivir is a nucleotide prodrug of an adenosine analog. This means that it mimics the function of another molecule that is used by the machine to build the virus. When Remdesivir sits in place of the molecule that was supposed to be in its place, it terminates the RNA transcription prematurely, thus preventing the virus from multiplying itself.


The usual Adverse events that were observed include: nausea, Elevated transaminase levels, Increase in prothrombin time without a change in the international normalized ratio (INR), and hypersensitivity.



Approvals:


Intravenous Remdesivir is approved for treatment of:


-         Mild to moderate Covid-19 in high-risk, non-hospitalized patients (a 3-day course is initiated within 7 days of symptom onset.)

-         Hospitalized patients with Covid-19 (a 5-day course)


FDA expanded the approval for the intravenous Remdesivir where It’s now available as FDA Emergency Use Authorization (EUA) for treatment of COVID-19 in non hospitalized and hospitalized pediatric patients:


-          Weighing 3.5 kg to 40 kg

-         Age <12 years and weighing > 3.5 kg.

-         Children as young as 28 days can be given the medication.



A phase II/III study was done by “Gilead Sciences” and the scientists observed that 75% of the pediatric patients had clinical improvement at day 10, and 85% showed improvement at last assessment. Adverse events were reported in 72% of the children, and 21 % of them had serious adverse event.



The FDA eventually assessed that the safety profile of Remdesivir is similar in pediatric subjects and adults.


Adverse events that were observed in pediatric patients:

Elevated levels of liver enzymes, allergic reactions, fever, shortness of breath, rash, nausea, sweating, or shivering. (2)

As a summary:

Drug Class Anti-Viral
Mechanism of Action Inhibits SARS-CoV-2 RNA-dependent RNA polymerase (RdRp), which is essential for viral replication
Route of Administration Intravenous (IV)
Side effects Nausea, Elevated transaminase levels, Increase in prothrombin time without a change in the international normalized ratio (INR), and hypersensitivity.

List of Services

    • Slide title

      Write your caption here
      Button
    • Slide title

      Write your caption here
      Button
    • Slide title

      Write your caption here
      Button
    • Slide title

      Write your caption here
      Button

    ABOUT THE AUTHOR

    Mohamad-Ali Salloum, PharmD

    Mohamad Ali Salloum LinkedIn Profile

    Mohamad-Ali Salloum is a Pharmacist and science writer. He loves simplifying science to the general public and healthcare students through words and illustrations. When he's not working, you can usually find him in the gym, reading a book, or learning a new skill.

    Share

    Recent articles:

    By Mohamad-Ali Salloum, PharmD June 12, 2026
    The deadly combo of Alcohol and Paracetamol!!
    By Mohamad-Ali Salloum, PharmD June 10, 2026
    References: Han A, Kim TH. Effects of self-compassion interventions on reducing depressive symptoms, anxiety, and stress: a meta-analysis. Mindfulness (N Y). 2023;[Epub ahead of print]. [pmc.ncbi.nlm.nih.gov] Li X, Malli MA, Cosco TD, Zhou G. The relationship between self-compassion and resilience in the general population: protocol for a systematic review and meta-analysis. JMIR Res Protoc. 2024;13:e60154. [researchpr...tocols.org] Buenrostro-Jáuregui MH, Muñoz-Sánchez S, Rojas-Hernández J, Alonso-Orozco AI, Vega-Flores G, Tapia-de-Jesús A, et al. A comprehensive overview of stress, resilience, and neuroplasticity mechanisms. Int J Mol Sci. 2025;26(7):3028. [mdpi.com] Pickersgill JW, Turco CV, Ramdeo K, Rehsi RS, Foglia SD, Nelson AJ. The combined influences of exercise, diet and sleep on neuroplasticity. Front Psychol. 2022;13:831819. [frontiersin.org] Ren B, Yuan Q, Cha S, Liu S, Zhang J, Guo G. Maladaptive neuroplasticity under stress: insights into neuronal and synaptic changes in the prefrontal cortex. Mol Neurobiol. 2025;[Epub ahead of print]. [link.springer.com] Blum K. The impact of chronic stress on brain function and structure. Neurosci Psychiatry Open Access. 2024;7(5). [openaccess...urnals.com] Wang X, Feng Z. A narrative review of empirical literature of behavioral activation treatment for depression. Front Psychiatry 2022;13:845138. [frontiersin.org]
    By Mohamad-Ali Salloum, PharmD June 8, 2026
    References: Maloney D. The Balance Between Self-Discipline and Self-Compassion. 2026. 3 Hominick G. Self-Compassion vs. Self-Criticism: Why Beating Yourself Up Doesn’t Work. Aletheia Counseling. 2026 Jan 16. Eyal N. Studies Show Self-Compassion Is the Motivator You’re Missing. Psychology Today. 2024 Apr 23. Hollinshead J. Self-Discipline vs. Self-Compassion. Peak Resilience. 2026.
    By Mohamad-Ali Salloum, PharmD June 4, 2026
    References: Quattash MS. The Depleted Mind: The Science of Decision Fatigue and Ego Depletion. Global Council for Behavioral Science. 2025. Available from: https://gc-bs.org/articles/the-depleted-mind-the-science-of-decision-fatigue-and-ego-depletion/ 5 Choudhury NA, Saravanan P. An integrative review on the causes and effects of decision fatigue. Front Cognit. 2026;4:1719312. Available from: https://www.frontiersin.org/journals/cognition/articles/10.3389/fcogn.2025.1719312/full 4 Schweitzer DR, Baumeister RF, Laakso EL, Ting J. Self-control, limited willpower and decision fatigue in healthcare settings. Intern Med J. 2023. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.16121 3 Ordali E, Pietrini P. Mental fatigue leads to loss of self-control and poor decision-making. Coverage in The Brighter Side of News. 2024. Available from: https://www.thebrighterside.news/post/mental-fatigue-leads-to-loss-of-self-control-and-poor-decision-making/ 2 Woodley BioReg. Decision Fatigue and Cognitive Load: A Scientific Perspective. Woodley BioReg. 2026. Available from: https://www.woodleybioreg.com/decision-fatigue-and-cognitive-load-a-scientific-perspective/ 1 Keller AJ. Decision Fatigue: What It Is and How It Affects Your Brain. Neurosity Guide. 2026. Available from: https://neurosity.co/guides/decision-fatigue-brain
    By Mohamad-Ali Salloum, PharmD June 2, 2026
    Understand the key difference between cravings and temptations, and learn how your body and mind influence your choices with simple, practical insights to improve self-control.
    By Mohamad-Ali Salloum, PharmD May 31, 2026
    Learn how to control your actions during intense emotions using science-backed techniques. Discover practical strategies like pausing, reframing, and grounding to stay calm, think clearly, and respond wisely in stressful situations.
    By Mohamad-Ali Salloum, PharmD May 29, 2026
    Lose weight while working!
    By Mohamad-Ali Salloum, PharmD May 27, 2026
    How are we using old software in a modern hardware?
    By Mohamad-Ali Salloum, PharmD May 26, 2026
    Understand why avoiding what makes you anxious brings short-term relief but worsens anxiety over time. Learn the science behind avoidance and effective ways to break the cycle.
    By Mohamad-Ali Salloum, PharmD May 25, 2026
    Learn how sleep affects productivity, cognitive function, memory, focus, and emotional well-being. A science-based guide to optimizing your performance through better sleep.
    More Posts